Kolumne, ORE

Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est.

10.05.2024 - 09:07:34

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen


Original-Research: ZEAL Network SE - from NuWays AG

Classification of NuWays AG to ZEAL Network SE

Company Name: ZEAL Network SE
ISIN: DE000ZEAL241

Reason for the research: 
Recommendation: Kaufen
from: 10.05.2024
Target price: EUR 53.00
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Henry Wendisch

Staggering Q1 kicks off new growth phase; chg est. & PT
 
On Wednesday, ZEAL released staggering Q1 results above expectations with
strong sales growth and better than expected profitability. Moreover, ZEAL
substantially improved marketing efficiency which drove customer growth to
record levels. In detail:
 
Strong Lottery business: Lottery billings came in better than expected at EUR
246m, +22% yoy (eNuW: EUR
234m) and were driven by 4x peak jackpots. Lottery sales grew by 28% yoy to
EUR 32m (eNuW: EUR 31m) thanks to the strong billings coupled with a solid
billings margin of 13.0%, up 0.9pp yoy (eNuW: 13.2%).
 
Upbeat Games adoption: Games contributed better than expected with billings
of EUR  31m (eNuW: EUR
25m) and sales of EUR 2.2m (eNuW: EUR 1.9m) driven by further additions to the
Games portfolio as well as user adoption with MAUs growing by 22% qoq to
22k (eNuW: 20k). Consequently, the ARPU stood at EUR 33.6 (vs. EUR 8.0 at
Lottery) highlighting the attractive user economics at Games.
 
Dynamic top-line: Q1 sales rose by 35% yoy to EUR  36.1m (eNuW: EUR  34.8m).
Based  on an average jackpot development, we expect a slight qoq sales
decline in Q2e (eNuW: EUR 34m; due to less user activity) before the  planned
expansion in the billings margin to above 15% (currently: 13%) should
unfold its posititve effect on sales from Q3e onwards (eNuW: EUR 38m in Q3e /
EUR 42m in Q4e).
 
EBITDA much better than expected: Q1 EBITDA came in at EUR 9.4m, +1% yoy
(eNuW: EUR 5.1m) despite heavy marketing expenses of EUR 13.4m (eNuW: EUR 14m),
but driven by higher than expected sales and lower than expected indirect
costs of EUR 3.6m (-20% qoq; eNuW: EUR 5.8m), as the majority of ramp-up costs
of the new social lottery will likely be incurred towards the end of the
year and not in Q1 and Q2.
 
Improved marketing efficiency: Costs per Lead decreased by 10% yoy to EUR 33
(eNuW: EUR 40), showing that customer acquisiton has become more efficient.
In sum, ZEAL accounted for 320k new registrations (+124% yoy; eNuW: 350k)
and grew their MAU in Lottery by 21% to 1.33m (eNuW: 1.26m).
 
Guidance well in reach: Management confirmed the guidance (see bottom
right), but based on our revised estimates, we expect a reach at the
upper-end of the guidance, due to the improved user base.
 
Therefore, we reiterate our BUY recommendation as well as ZEAL's position
in the NuWays' AlphaList
with an increased PT of EUR 53.00 (old: EUR 51.00), based on DCF.

You can download the research here:
http://www.more-ir.de/d/29651.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: CeoTronics AG (von Montega AG): Kaufen Original-Research: CeoTronics AG - von Montega AG 04.12.2024 / 16:36 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. (Boerse, 04.12.2024 - 16:37) weiterlesen...

Original-Research: GBC Insider Focus Index (von GBC AG): Indexupdate 2024KW49 Original-Research: GBC Insider Focus Index - von GBC AG 04.12.2024 / 16:00 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. (Boerse, 04.12.2024 - 16:01) weiterlesen...

Original-Research: OTRS AG (von Montega AG): Verkaufen (zuvor: Kaufen) Original-Research: OTRS AG - von Montega AG 04.12.2024 / 10:40 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. (Boerse, 04.12.2024 - 10:41) weiterlesen...

Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy Original-Research: H2APEX Group SCA - von First Berlin Equity Research GmbH 03.12.2024 / 14:50 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. (Boerse, 03.12.2024 - 14:51) weiterlesen...

Original-Research: Warimpex Finanz- und Beteiligungs-AG (von East Value Resea... Original-Research: Warimpex Finanz- und Beteiligungs-AG - from East Value Research GmbH 03.12.2024 / 13:46 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 03.12.2024 - 13:47) weiterlesen...

Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): BUY Original-Research: LAIQON AG - from First Berlin Equity Research GmbH 03.12.2024 / 13:20 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 03.12.2024 - 13:21) weiterlesen...